- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast Growth Factor-23—A Potential Uremic Toxin
Authors
Keywords
-
Journal
Toxins
Volume 8, Issue 12, Pages 369
Publisher
MDPI AG
Online
2016-12-08
DOI
10.3390/toxins8120369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGF23 signaling impairs neutrophil recruitment and host defense during CKD
- (2016) Jan Rossaint et al. JOURNAL OF CLINICAL INVESTIGATION
- C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population
- (2016) Maria Bożentowicz-Wikarek et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients
- (2016) Y. Coskun et al. TRANSPLANTATION PROCEEDINGS
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients
- (2015) I. H. Bleskestad et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia
- (2015) Xiaoping Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
- (2015) T. Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Niacin on FGF23 Concentration in Chronic Kidney Disease
- (2014) Madhumathi Rao et al. AMERICAN JOURNAL OF NEPHROLOGY
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- FGF23 promotes renal calcium reabsorption through the TRPV5 channel
- (2014) Olena Andrukhova et al. EMBO JOURNAL
- FGF23 regulates renal sodium handling and blood pressure
- (2014) Olena Andrukhova et al. EMBO Molecular Medicine
- Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription
- (2014) Tomer Meir et al. KIDNEY INTERNATIONAL
- FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy
- (2013) Chad D. Touchberry et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism
- (2013) Piotr Kuczera et al. CLINICAL ENDOCRINOLOGY
- Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
- (2013) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of a 300 000-IU Loading Dose of Ergocalciferol (Vitamin D2) on Circulating 1,25(OH)2-Vitamin D and Fibroblast Growth Factor-23 (FGF-23) in Vitamin D Insufficiency
- (2013) C. Turner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor 23, Klotho, and Disordered Mineral Metabolism in Chronic Kidney Disease: Unraveling the Intricate Tapestry of Events and Implications for Therapy
- (2013) Orlando M. Gutiérrez JOURNAL OF RENAL NUTRITION
- Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects
- (2013) K. J. Martin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FGF-23 Regulates CYP27B1 Transcription in the Kidney and in Extra-Renal Tissues
- (2013) Ankanee Chanakul et al. PLoS One
- Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion
- (2013) Hannes Olauson et al. PLoS Genetics
- FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway
- (2012) Olena Andrukhova et al. BONE
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
- (2012) Kenneth Lim et al. CIRCULATION
- Randomized Trial Assessing the Effects of Ergocalciferol Administration on Circulating FGF23
- (2012) S.-A. M. Burnett-Bowie et al. Clinical Journal of the American Society of Nephrology
- Acute Effects of Very-Low-Protein Diet on FGF23 Levels: A Randomized Study
- (2012) B. Di Iorio et al. Clinical Journal of the American Society of Nephrology
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Calcium Deficiency Reduces Circulating Levels of FGF23
- (2012) M. E. Rodriguez-Ortiz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial
- (2012) Mhairi Sigrist et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
- (2012) Xiaofang Wang et al. PLoS Genetics
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
- (2011) J. Kendrick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol
- (2011) D. Hansen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
- (2011) M. Koizumi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
- (2011) E. G. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis
- (2011) Mark R. Haussler et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Fibroblast Growth Factor 23 and Fetuin A are Independent Predictors for the Coronary Artery Disease Extent in Mild Chronic Kidney Disease
- (2010) M. Kanbay et al. Clinical Journal of the American Society of Nephrology
- Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease
- (2010) S. M. Moe et al. Clinical Journal of the American Society of Nephrology
- Cardioprotective effect of calcineurin inhibition in an animal model of renal disease
- (2010) Giovana S. Di Marco et al. EUROPEAN HEART JOURNAL
- Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term
- (2010) Ayse Kubat Uzum et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice
- (2010) Ralph A. Meyer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
- (2010) M. Wolf JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
- (2010) Katherine Wesseling-Perry et al. KIDNEY INTERNATIONAL
- FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
- (2010) S. Seiler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
- (2009) J. B. Wetmore et al. Clinical Journal of the American Society of Nephrology
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- Ablation of theGalnt3Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite IncreasedFgf23Expression
- (2009) Shoji Ichikawa et al. ENDOCRINOLOGY
- Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia*
- (2009) Yukiko Aono et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
- (2009) Belinda J. Schouten et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
- (2009) Takashi Shimada et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Intestinal Npt2b Plays a Major Role in Phosphate Absorption and Homeostasis
- (2009) Y. Sabbagh et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule
- (2009) E. G. Farrow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis
- (2009) M. Shawkat Razzaque Nature Reviews Endocrinology
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
- (2009) G. Jean et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients
- (2008) S. C. Cheng et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now